Pet health and wellness company PetIQ (PETQ) reported a 15.5% jump in sales, while net loss widened to $3.39 million. The increased net loss was largely due to the one-time non-cash tax expense of $3.4 million, or $0.16 per diluted share for the revaluation of deferred tax assets, and a provisional tax expense of $0.2 million.
Gross profit for the quarter increased 38.1% year-over-year, driven by improved net sales which created improved sales mix of categories that were more profitable and procurement improvements.
PetIQ also announced that it has reached an agreement to open 20 veterinarian clinics within Walmart stores. These clinics will be opened between March and the end of the second quarter of 2018.
Outlook
The company expects full year 2018 net sales in the range of $450 million to $500 million, up 69% to 87% year-over-year. Adjusted EBITDA is expected in the range of $40 million to $45 million, up 79% to 102% year-over-year.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
